SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Thomas F. Babor, Peter G. Miller, McCarthyism, conflict of interest and Addiction's new transparency declaration procedures, Addiction, 2014, 109, 3
  2. 2
    John P.A. Ioannidis, Marcus R. Munafò, Paolo Fusar-Poli, Brian A. Nosek, Sean P. David, Publication and other reporting biases in cognitive sciences: detection, prevalence, and prevention, Trends in Cognitive Sciences, 2014, 18, 5, 235

    CrossRef

  3. 3
    Jennifer J. Ware, Marcus R. Munafò, Significance chasing in research practice: causes, consequences and possible solutions, Addiction, 2014, 109, 8
  4. 4
    Gerhard Büringer, Anil Batra, Andreas Heinz, Hans-Jürgen Rumpf, Neufassung der Deklaration konkurrierender Interessen und der Rubriken der Zeitschrift SUCHT, SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice, 2013, 59, 4, 185

    CrossRef

  5. 5
    K. Morphett, J. Lucke, C. Gartner, A. Carter, C. Meurk, W. Hall, Public Attitudes Toward the Treatment of Nicotine Addiction, Nicotine & Tobacco Research, 2013, 15, 9, 1617

    CrossRef

  6. 6
    Kenneth D. Ward, Taghrid Asfar, Radwan Al Ali, Samer Rastam, Mark W. Vander Weg, Thomas Eissenberg, Wasim Maziak, Randomized trial of the effectiveness of combined behavioral/pharmacological smoking cessation treatment in Syrian primary care clinics, Addiction, 2013, 108, 2
  7. 7
    Patrick Basham, John C. Luik, PRESCRIPTION FOR CONFLICT: WHY THE ALLIANCE BETWEEN THE PHARMACEUTICAL INDUSTRY AND THE ANTI-TOBACCO MOVEMENT IS NOT IN THE BEST INTERESTS OF SMOKERS, Economic Affairs, 2012, 32, 2
  8. 8
    Peter Dome, Over-the-counter nicotine replacement therapy for everyone: Is it the best solution?, Medical Hypotheses, 2011, 77, 6, 1048

    CrossRef

  9. 9
    John R. Hughes, The hardening hypothesis: Is the ability to quit decreasing due to increasing nicotine dependence? A review and commentary, Drug and Alcohol Dependence, 2011, 117, 2-3, 111

    CrossRef

  10. 10
    NATASHA M. P. GREENE, ELEANOR M. TAYLOR, SUZANNE H. GAGE, MARCUS R. MUNAFÒ, INDUSTRY FUNDING AND PLACEBO QUIT RATE IN CLINICAL TRIALS OF NICOTINE REPLACEMENT THERAPY: A COMMENTARY ON ETTER ET AL. (2007), Addiction, 2010, 105, 12
  11. 11
    Yu Bai, Yong-Fa Wu, Dong Wang, Yang Xia, Jun Gao, Duo-Wu Zou, Zhao-Shen Li, Internal validity of randomized controlled trials reported in major gastrointestinal and surgical endoscopy journals in 2008, Surgical Endoscopy, 2010, 24, 5, 1158

    CrossRef

  12. 12
    JEAN-FRANÇOIS ETTER, JOHN STAPLETON, RESPONSE TO GREENE ET AL.: INDUSTRY FUNDING AND PLACEBO QUIT RATE IN CLINICAL TRIALS OF NICOTINE REPLACEMENT THERAPY: A COMMENTARY ON ETTER ET AL. (2007), Addiction, 2010, 105, 12
  13. 13
    Kanu Okike, Mininder S. Kocher, Erin X. Wei, Charles T. Mehlman, Mohit Bhandari, Accuracy of Conflict-of-Interest Disclosures Reported by Physicians, New England Journal of Medicine, 2009, 361, 15, 1466

    CrossRef

  14. 14
    Jean-François Etter, John Stapleton, Citations to trials of nicotine replacement therapy were biased toward positive results and high-impact-factor journals, Journal of Clinical Epidemiology, 2009, 62, 8, 831

    CrossRef

  15. 15
    John R. Hughes, How confident should we be that smoking cessation treatments work?, Addiction, 2009, 104, 10
  16. 16
    Kanu Okike, Mininder S. Kocher, Charles T. Mehlman, Mohit Bhandari, Industry-sponsored research, Injury, 2008, 39, 6, 666

    CrossRef

  17. 17
    Marcel D. Waldinger, Dave H. Schweitzer, Premature Ejaculation and Pharmaceutical Company-Based Medicine: The Dapoxetine Case, The Journal of Sexual Medicine, 2008, 5, 4
  18. 18
    Keir Lewis, Smoking cessation—Making quitting a real option, Respiratory Medicine: COPD Update, 2007, 3, 4, 128

    CrossRef

  19. 19
    PETER J. ADAMS, TRUSTING RESEARCHERS TO POLICE THEMSELVES?, Addiction, 2007, 102, 7
  20. 20
    Andreas Lundh, Sergio Sismondo, Joel Lexchin, Octavian A Busuioc, Lisa Bero, Industry sponsorship and research outcome, The Cochrane Library,
  21. 21
    Kate Cahill, Lindsay F Stead, Tim Lancaster, Nicotine receptor partial agonists for smoking cessation, The Cochrane Library,
  22. You have free access to this content22
    Lindsay F Stead, Rafael Perera, Chris Bullen, David Mant, Jamie Hartmann-Boyce, Kate Cahill, Tim Lancaster, Nicotine replacement therapy for smoking cessation, The Cochrane Library,
  23. You have free access to this content23
    Lindsay F Stead, Rafael Perera, Chris Bullen, David Mant, Tim Lancaster, Nicotine replacement therapy for smoking cessation, The Cochrane Library,
  24. You have free access to this content24
    Kate Cahill, Sarah Stevens, Rafael Perera, Tim Lancaster, Pharmacological interventions for smoking cessation: an overview and network meta-analysis, The Cochrane Library,